Literature DB >> 23193024

Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.

Zhiyong Du1, Cuifeng Wei, Jiqi Yan, Baosan Han, Mingjun Zhang, Chenghong Peng, Yingbin Liu.   

Abstract

Mesenchymal stem cell (MSC) therapy can prevent hepatic parenchymal cell loss and promote tissue repair. However, poor MSC engraftment is one of the primary barriers to the effectiveness of cell therapy because culture-expanded MSCs progressively down-regulate C-X-C chemokine receptor type 4 (CXCR4) expression and lose their ability to migrate toward a concentration gradient of stromal cell-derived factor 1a (SDF1a). In this study, we investigated whether a CXCR4-MSC infusion could protect hepatocytes and stimulate regeneration in 50% reduced size liver transplantation (RSLT). Rats that underwent 50% RSLT were randomly divided into 3 groups: a phosphate-buffered solution group (PBS), a green fluorescent protein (GFP)-MSC group, and a CXCR4-MSC group. Rats received 1 mL of PBS with or without a resuspension of GFP-MSCs or CXCR4-MSCs. The factors secreted by MSCs, the graft function, the apoptosis and proliferation of hepatocytes, the efficacy of MSC engraftment, and the expression of SDF1α, albumin (Alb), and cytokeratin 18 (CK18) in engrafted GFP-positive MSCs were assessed. A systemic infusion of GFP-MSCs led to a reduction of the release of liver injury biomarkers and apoptosis of hepatocytes; CXCR4 overexpression did not further reduce the liver injury. However, CXCR4 overexpression enhanced MSC engraftment in liver grafts, improved the effect on the proliferation of hepatocytes, and thus provided a significant 1-week survival benefit. SDF1α expression in grafts was elevated after transplanted CXCR4-MSCs were recruited to the remnant liver. However, engrafted MSCs did not express the markers of hepatocytes, including Alb and CK18, in vivo 168 hours after transplantation. CXCR4 overexpression enhanced the mobilization and engraftment of MSCs into small-for-size liver grafts, in which these cells promoted the early regeneration of the remnant liver not by direct differentiation but perhaps by a paracrine mechanism.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23193024     DOI: 10.1002/lt.23577

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  18 in total

1.  Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4.

Authors:  Na Li; Yue-Jin Yang; Hai-Yan Qian; Qing Li; Qian Zhang; Xiang-Dong Li; Qiu-Ting Dong; Hui Xu; Lei Song; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 2.  Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.

Authors:  Miaohua Mo; Shan Wang; Ying Zhou; Hong Li; Yaojiong Wu
Journal:  Cell Mol Life Sci       Date:  2016-05-03       Impact factor: 9.261

3.  Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration.

Authors:  Hu-Cheng Ma; Xiao-Lei Shi; Hao-Zhen Ren; Xian-Wen Yuan; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

4.  CXCR4 receptor overexpression in mesenchymal stem cells facilitates treatment of acute lung injury in rats.

Authors:  Jing-Xian Yang; Nan Zhang; Han-Wei Wang; Peng Gao; Qing-Ping Yang; Qing-Ping Wen
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

5.  Over-expression of HSP47 augments mouse embryonic stem cell smooth muscle differentiation and chemotaxis.

Authors:  Mei Mei Wong; Xiaoke Yin; Claire Potter; Baoqi Yu; Hao Cai; Elisabetta Di Bernardini; Qingbo Xu
Journal:  PLoS One       Date:  2014-01-16       Impact factor: 3.240

Review 6.  Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and Survival.

Authors:  Adam Nowakowski; Piotr Walczak; Barbara Lukomska; Miroslaw Janowski
Journal:  Stem Cells Int       Date:  2016-05-03       Impact factor: 5.443

7.  Regenerative Potential of Mesenchymal Stromal Cells: Age-Related Changes.

Authors:  Flavia Bruna; David Contador; Paulette Conget; Benjamín Erranz; Claudia L Sossa; Martha L Arango-Rodríguez
Journal:  Stem Cells Int       Date:  2016-05-09       Impact factor: 5.443

Review 8.  Genetic modification by overexpression of target gene in mesenchymal stromal cell for treating liver diseases.

Authors:  Chenxia Hu; Lingfei Zhao; Lanjuan Li
Journal:  J Mol Med (Berl)       Date:  2021-01-02       Impact factor: 4.599

Review 9.  Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies.

Authors:  Naomi D'souza; Filippo Rossignoli; Giulia Golinelli; Giulia Grisendi; Carlotta Spano; Olivia Candini; Satoru Osturu; Fabio Catani; Paolo Paolucci; Edwin M Horwitz; Massimo Dominici
Journal:  BMC Med       Date:  2015-08-12       Impact factor: 8.775

Review 10.  In Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases.

Authors:  Chenxia Hu; Lanjuan Li
Journal:  Stem Cells Int       Date:  2015-08-05       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.